CONTRIBUTORS TO VOLUME 2 2 Numbers in parentheses refer to the pages on which the authors’ contributions begin.
RICHARDH . ADAMSON,Laboratory of Chemical Pharmacology, National Cancer Institute, National Institutes of Health, Bethesrlu, Maryland (57) PAULH . BLACK,Department of Medicine, Harvard Medical School, and Infectious Disease Unit, Massachusetts General Hospital, Boston, Massachusetts ( 203) IIH-NAN CHOU,Department of Medicine, Harvard Medical School, and Infectious Disease Unit, Massachusetts General Hospital, Boston, Massachusetts (203) RAYMONDV. GILDEN,Flow Laboratories, Inc., Rockoille, Margland ( 157)
J. M . HAMILTON,Department of Experimental Pathology and Cancer Research, School of Medicine, University of Lee& Leech, England ( 1 ) RICHARDROBLIN, Departments of Microbiology and Molecular Genetics, Harvard Medical School, and Infectious Disease Unit, Massachusetts General Hospital, Boston, Massachusetts ( 203) SUSANM. SIEBER,Laboratory of Chemical Pharmacology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland ( 57) OSIASSTUTMAN,Memorial Sloan-Kettering Cancer Center, New York, New York (261)
vii